Page last updated: 2024-08-21

isoxazoles and Parkinson Disease, Secondary

isoxazoles has been researched along with Parkinson Disease, Secondary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kanemaru, A; Kojima, T; Tokashiki, S; Ueda, Y	1
Casey, DE; Gerlach, J; Hetmar, O; Kaldan, B; Korsgaard, S; Mikkelsen, LB	1
Fensbo, C; Høyberg, OJ; Lingjaerde, O; Remvig, J; Salvesen, I; Sloth-Nielsen, M	1

Trials

2 trial(s) available for isoxazoles and Parkinson Disease, Secondary

Article	Year
The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist. Archives of general psychiatry, 1982, Volume: 39, Issue:9 Topics: Adult; Aged; Analgesics; Antipsychotic Agents; Blinking; Clinical Trials as Topic; Confusion; Dizziness; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxazoles; Parkinson Disease, Secondary; Placebos; Vomiting	1982
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations. Acta psychiatrica Scandinavica, 1993, Volume: 88, Issue:6 Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Denmark; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Norway; Parkinson Disease, Secondary; Perphenazine; Piperidines; Prevalence; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index	1993

Article

Year

The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.

Archives of general psychiatry, 1982, Volume: 39, Issue:9

Topics: Adult; Aged; Analgesics; Antipsychotic Agents; Blinking; Clinical Trials as Topic; Confusion; Dizziness; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxazoles; Parkinson Disease, Secondary; Placebos; Vomiting

1982

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.

Acta psychiatrica Scandinavica, 1993, Volume: 88, Issue:6

Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Denmark; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Norway; Parkinson Disease, Secondary; Perphenazine; Piperidines; Prevalence; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index

1993

Other Studies

1 other study(ies) available for isoxazoles and Parkinson Disease, Secondary

Article	Year
Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease. Biochemical and biophysical research communications, 2012, Nov-23, Volume: 428, Issue:3 Topics: Animals; Anticonvulsants; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Drug Therapy, Combination; Gene Expression; Gene Expression Profiling; Isoxazoles; Levodopa; Male; Oligonucleotide Array Sequence Analysis; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Zonisamide	2012

Article

Year

Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.

Biochemical and biophysical research communications, 2012, Nov-23, Volume: 428, Issue:3

Topics: Animals; Anticonvulsants; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Drug Therapy, Combination; Gene Expression; Gene Expression Profiling; Isoxazoles; Levodopa; Male; Oligonucleotide Array Sequence Analysis; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; Zonisamide

2012